Dr. Reddy’s Laboratories Inc focuses on reducing these barriers to good health and is committed to improving access to needed medications across the United States.
Delivering On the Promise of Good Health
Access to many expensive, life-changing medicines remains a hurdle for countless individuals. Dr. Reddy’s Laboratories Inc focuses on reducing these barriers to good health and is committed to improving access to needed medications across the United States.
GOOD HEALTH CANNOT WAIT
Determined to meet these crucial needs with agility and innovation, Dr. Reddy’s has set forth 5 promises that each of its employees live by and work toward every day.
RESOLVING CHALLENGES THAT JUST FEW CAN
Dr. Reddy’s makes medicines more affordable by managing the entire value chain—producing the active ingredients, developing formulations, and distributing them over a streamlined supply chain. The company’s in-depth knowledge of intellectual property and regulation also contributes to bringing high-quality, regulatorycompliant medicines within patients’ reach.
To build and diversify, the company annually puts more than 10% of its revenue back into research and development to uncover new opportunities for good health. This reinvestment has resulted in one of the more expansive offerings in the industry, spanning major therapeutic areas including anti-infective, cardiovascular, dermatology, gastroenterology, oncology, pain management, and pediatrics. The company offers a variety of forms, including capsules, injectables, tablets, and topical creams.
A LONG JOURNEY THAT’S JUST BEGINNING
Dr. Reddy’s sees medicines not just as molecules but also as tools that help people get back to health and promote wellness. This viewpoint continues to fuel the company’s growth during an exciting yet complex journey that began more than 3 decades ago.
Millions of people have benefited from the medicines made by Dr. Reddy’s, which is part of a global, vertically integrated pharmaceutical company with 4 finished-dosage facilities serving North America. With 3 businesses (global generics, pharmaceutical services and active ingredients, and proprietary products), the company strives to meet the undermet and unmet needs of partners and patients, providing a selection of active pharmaceutical ingredients, biosimilars, branded products, customer pharmaceutical services, differentiated formulations, and generics.
As advanced therapeutics and emerging formulations become available, Dr. Reddy’s and its subsidiary, Promius Pharma, will continue to bring value to the pharmacy and its customers.
For more information, visit drreddys-cps.com.